• Facebook
  • X
  • Instagram
MYELOMA360
  • Home
  • MYInsights
  • MYBoard
  • Strategy & Consulting
Select Page

Inspirational Leader Shines Her Light Outward to Others

by MM360 Staff | May 12, 2025 | Uncategorized

Source: CureToday articles Dr. Susan Rux, a respected nursing leader and researcher, empowers teams, mentors future leaders, and advances inclusive clinical research in kidney cancer. Read More

Advances in Radiation Improve Precision in Brain Cancer Therapy

by MM360 Staff | May 12, 2025 | Uncategorized

Source: CureToday articles The field of radiation oncology has advanced in brain cancer treatment with precise therapeutic approaches including proton and carbon therapy. Read More

Finding Strength and Joy During My Stage 4 Kidney Cancer Experience

by MM360 Staff | May 12, 2025 | Uncategorized

Source: CureToday articles Living with stage 4 kidney cancer has taught me to embrace the present, cherish connection and find gratitude each day in unexpected places. Read More

IHC Testing Aims to Expand Personalized Treatment in Lung Cancer

by MM360 Staff | May 12, 2025 | Uncategorized

Source: CureToday articles Investigators are using MET immunohistochemistry testing and FDA-approved profiling tools to personalize care and address unmet needs in NSCLC treatment. Read More

Lymphedema Makes Summer Preparations Challenging After Breast Cancer

by MM360 Staff | May 12, 2025 | Uncategorized

Source: CureToday articles Summer heat can worsen my lymphedema, but I’ve learned simple ways to stay cool, reduce swelling and protect my arms — here’s what helps me most. Read More

Understanding the Evolving Strategies in WM Care and Management

by MM360 Staff | May 12, 2025 | Uncategorized

Source: CureToday articles An expert reflects on the treatment landscape of Waldenström macroglobulinemia, emphasizing diagnostics, collaboration and managing neuropathy effectively. Read More
« Older Entries
Next Entries »

Recent Content

  • In vivo CAR-T exhibits activity in advanced multiple myeloma
  • FDA backs faster development of new therapy for hard-to-treat AML
  • The efficacy and safety of anti-CD38 monoclonal antibodies in transplant-ineligible newly diagnosed multiple myeloma: A systematic review and meta-analysis of randomized controlled trials
  • Predictive values of baseline 18F-FDG PET/CT for toxicities and outcomes in patients with relapsed or refractory multiple myeloma following BCMA CAR T-cell therapy
  • Correction: Chen et al. The Efficacy and Safety of Tandem Transplant Versus Single Stem Cell Transplant for Multiple Myeloma Patients: A Systematic Review and Meta-Analysis. Diagnostics 2024, 14, 1030
  • Comparison of Standard of Care with or Without a PD-1/PD-L-1 Inhibitor for the Treatment of Multiple Myeloma: A Systematic Review and Meta-Analysis of Phase II and III Randomized Controlled Trials
  • Combo treatment may offer new hope to astrocytoma patients: Trial
  • Reduced-versus Standard-dose Melphalan as Single-agent Conditioning Regimen in Auto HSCT for Multiple Myeloma: A Systematic Review and Meta-Analysis
  • Dosing begins in trial testing Enhertu for ovarian cancer
  • (no title)
  • Facebook
  • X
  • Instagram
©2016-2025 MYELOMA360 & Connect BioMed
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
SettingsAccept
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT